» Articles » PMID: 2695067

Inhibition of Hyaluronan Uptake in Lymphatic Tissue by Chondroitin Sulphate Proteoglycan

Overview
Journal Biochem J
Specialty Biochemistry
Date 1989 Dec 15
PMID 2695067
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Afferent lymph vessels entering the popliteal lymph nodes of sheep were infused with [3H]acetyl-labelled hyaluronan [HA; Mr of (0.85-1.2) x 10(5)] for up to 4 h at a rate of 17.4-23.1 micrograms/h. As much as 22.8 micrograms (99%) of infused [3H]HA was taken up by the node per h and degraded. During this interval it was observed that infused HA polymers of higher Mr were absorbed by the node to a greater degree than those of lower Mr. When proteoglycan monomer (PG; Mr 5 x 10(5); 400 micrograms of hexuronic acid/h) was infused concurrently with [3H]HA, the absolute amount of radioactivity appearing in efferent lymph (i.e. labelled material not absorbed by the node) increased, whereas the amount of labelled metabolites of low Mr was reduced considerably. During this period the Mr distribution of labelled HA in efferent outflow reverted to that of the infused material within 30-60 min. Our findings suggest that PG subunits and their chondroitin sulphate chains compete with HA for uptake into the peripheral lymph node of sheep. This indicates that PG, chondroitin sulphate and HA share the same pathway of elimination in this tissue, and is consistent with the view that the lymph node is involved in the metabolic turnover of normal intracellular matrix.

Citing Articles

The human hyaluronan receptor for endocytosis (HARE/Stabilin-2) is a systemic clearance receptor for heparin.

Harris E, Weigel J, Weigel P J Biol Chem. 2008; 283(25):17341-50.

PMID: 18434317 PMC: 2427350. DOI: 10.1074/jbc.M710360200.


Biosynthesis of glycosaminoglycans and proteoglycans by the lymph node.

Brown T, Kimpton W, Fraser J Glycoconj J. 2001; 17(11):795-805.

PMID: 11443281 DOI: 10.1023/a:1010940826602.


LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan.

Banerji S, Ni J, Wang S, Clasper S, Su J, Tammi R J Cell Biol. 1999; 144(4):789-801.

PMID: 10037799 PMC: 2132933. DOI: 10.1083/jcb.144.4.789.


Articular cartilage and osteoarthrosis. The role of molecular markers to monitor breakdown, repair and disease.

Lohmander L J Anat. 1994; 184 ( Pt 3):477-92.

PMID: 7928637 PMC: 1259956.

References
1.
Silpananta P, Dunstone J, OGSTON A . Fractionation of a hyaluronic acid preparation in a density gradient. The isolation and identification of a chondroitin sulphate. Biochem J. 1967; 104(2):404-9. PMC: 1270600. DOI: 10.1042/bj1040404. View

2.
Laurent T, Fraser J . The properties and turnover of hyaluronan. Ciba Found Symp. 1986; 124:9-29. DOI: 10.1002/9780470513385.ch2. View

3.
Ohya T, Kaneko Y . Novel hyaluronidase from streptomyces. Biochim Biophys Acta. 1970; 198(3):607-9. DOI: 10.1016/0005-2744(70)90139-7. View

4.
Revell P, Muir H . The excretion and degradation of chondroitin 4-sulphate administered to guinea pigs as free chondroitin sulphate and as proteoglycan. Biochem J. 1972; 130(2):597-606. PMC: 1174440. DOI: 10.1042/bj1300597. View

5.
Wood K, Wusteman F, Curtis C . The degradation of intravenously injected chondroitin 4-sulphate in the rat. Biochem J. 1973; 134(4):1009-13. PMC: 1177909. DOI: 10.1042/bj1341009. View